US Drug Recall Register

FDA Drug Recalls

14,450 recalls · Class II, newest first

Class II · Moderate risk Terminated

fentaNYL

Reason Lack of Assurance of Sterility; product has the potential to leak.

SCA Pharmaceuticals NDC 70004-0202-40 D-1009-2017
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of Assurance of Sterility; product has the potential to leak.

SCA Pharmaceuticals NDC 70004-0201-40 D-1008-2017
Class II · Moderate risk Terminated

BUPIVacaine HCl 0.1% PF

Reason Lack of Assurance of Sterility; product has the potential to leak.

SCA Pharmaceuticals NDC 70004-0060-40 D-1005-2017
Class II · Moderate risk Terminated

PHENYLephrine HCl 10 mg in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-1004-2017
Class II · Moderate risk Terminated

Diltiazem 125 mg in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-1002-2017
Class II · Moderate risk Terminated

ceFAZolin 3 g added to 100 mL 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-1001-2017
Class II · Moderate risk Terminated

fentaNYL

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-1000-2017
Class II · Moderate risk Terminated

morphine sulfate 1 mg per mL in 0.9% Sodium Chloride

Reason Lack of Assurance of Sterility: Product made with recalled 0.9% sodium chloride bags which have the potential to leak.

SCA Pharmaceuticals D-0999-2017
Class II · Moderate risk Terminated

0.9% Sodium Chloride Injection

Reason Lack of Assurance of Sterility: Bags have the potential to leak.

Baxter Healthcare Corporation D-0973-2017